$LAES

O'Hara John Charles sold $16K of LAES

O'Hara John Charles (Chief Financial Officer) sold 4,689 shares of SEALSQ Corp (LAES) at $3.50 on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'Hara John Charles
Published May 29, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 29, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LAES
Neutral
medium confidence
Mentioned
$LAES
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LAESNeutralLow
01

Why it matters

Because the sale is pre-arranged, it is less likely to reflect new negative information; traders may still monitor for follow-on insider activity or other catalysts.

02

Market read

Provides a fresh, timestamped insider-selling datapoint for LAES, but with reduced bearish interpretation due to 10b5-1 pre-arrangement.

03

What to watch

The article does not state whether other insiders bought/sold, nor does it quantify total insider ownership changes beyond the post-transaction holdings.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-29 after the sale executed on 2026-05-27

Background

The article is an SEC Form 4 insider transaction disclosure for SEALSQ Corp (LAES), showing an officer/director sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$LAESNeutralMedium confidence
Context

SEALSQ CFO John Charles sold 4,689 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other negative catalysts.

Evidence & confidence

The filing provides a concrete datapoint (sale size/price) but does not indicate new operational or financial developments, and the sale is explicitly under a pre-arranged plan.

Market effects

Minimal; this is company-specific insider activity without sector-wide implications in the article.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can be routine liquidity events; the disclosure may be misread as bearish without corroborating fundamentals.

Key entities

  • SEALSQ Corp

    Company whose shares were sold by an officer under a 10b5-1 plan.

  • O'Hara John Charles

    Chief Financial Officer and officer/director who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WKEYLow

WISeKey International Holding Ltd.: WISeKey, SEALSQ and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center

WISeKey (SIX: WIHN, NASDAQ: WKEY) and its subsidiary SEALSQ (NASDAQ: LAES) signed an MoU with the Canton of Jura to establish a CHF 40-60 million Post-Quantum Semiconductor and Cybersecurity Center in Switzerland, aiming to create 250+ jobs and enhance Swiss technological sovereignty. The center will focus on post-quantum semiconductor technologies, including SEALSQ's QS7001 Quantum Shield, and is expected to be operational within 6 years.

Med

Sealsq Releases 1H 2026 Financial Results

Sealsq Corp. reported a 23.5% narrower net loss of $27.8M (1H 2026) and 131.0% revenue growth to $11.2M, driven by quantum-resistant security chip adoption. North America contributed 50% of sales. FY2026 guidance: $27.0M-$36.0M revenue. Analysts: 5 buys, 1 hold. Gross margin: 48.0%.

$LAESLow

SEALSQ Corp (LAES): Financial results for H1 2026

SEALSQ Corp (LAES) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 SEALSQ Reports H1 2026 Financial and Operational Results Revenue Increases 131% to $11.2 Million; FY2026 Guidance Reaffirmed Cash and Cash Equivalents of $486.1 Million at June 30, 2026, Support Continued R&D, Product Certification and Acquisition Integration Confere